Holen Sie sich die Stockscreener-App
1.79
2.19%
-0.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PETS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$1.83
Offen:
$1.82
24-Stunden-Volumen:
32,598
Relative Volume:
0.29
Marktkapitalisierung:
$38.24M
Einnahmen:
$182.67M
Nettoeinkommen (Verlust:
$-64.87M
KGV:
-0.5738
EPS:
-3.1193
Netto-Cashflow:
$-22.92M
1W Leistung:
-0.56%
1M Leistung:
-15.57%
6M Leistung:
-49.58%
1J Leistung:
-45.43%
1-Tages-Spanne:
$1.79
$1.83
1-Wochen-Bereich:
$1.73
$1.84
52-Wochen-Spanne:
$1.57
$4.10
Petmed Express Inc Stock (PETS) Company Profile
Firmenname
Petmed Express Inc
Sektor
Branche
Telefon
(561) 426-4444
Adresse
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Compare PETS vs HITI, SCNX, POM, WGRX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PETS
Petmed Express Inc
|
1.79 | 38.24M | 182.67M | -64.87M | -22.92M | -3.1193 |
HITI
High Tide Inc
|
2.21 | 194.19M | 452.61M | -35.30M | 13.25M | -0.3863 |
SCNX
Scienture Holdings Inc
|
0.3683 | 14.96M | 656.60K | -16.79M | -11.12M | -1.0743 |
POM
Pomdoctor Ltd Adr
|
1.33 | 9.92M | 0 | 0 | 0 | 0.00 |
WGRX
Wellgistics Health Inc
|
2.82 | 7.09M | 14.03M | -76.59M | -13.73M | -41.45 |
Petmed Express Inc Stock (PETS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-05-25 | Eingeleitet | Lake Street | Buy |
| 2022-01-20 | Hochstufung | Sidoti | Neutral → Buy |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Underweight |
| 2021-10-01 | Eingeleitet | Jefferies | Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-06-03 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-03-05 | Hochstufung | Sidoti | Neutral → Buy |
| 2021-01-27 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-08-19 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2020-03-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-02-24 | Herabstufung | Sidoti | Buy → Neutral |
| 2019-08-16 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-06-15 | Eingeleitet | CL King | Neutral |
| 2017-08-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2017-07-24 | Hochstufung | Northcoast | Neutral → Buy |
| 2016-05-09 | Hochstufung | Craig Hallum | Sell → Hold |
| 2016-02-04 | Eingeleitet | Credit Suisse | Underperform |
| 2010-07-19 | Herabstufung | CL King | Strong Buy → Accumulate |
| 2010-07-19 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-05-25 | Herabstufung | Wedbush | Neutral → Underperform |
| 2010-05-06 | Bestätigt | Wedbush | Neutral |
| 2010-03-23 | Herabstufung | Janney Mntgmy Scott | Buy → Neutral |
| 2010-03-18 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2010-02-16 | Bestätigt | CL King | Strong Buy |
| 2009-07-21 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2009-01-07 | Eingeleitet | CL King | Strong Buy |
Alle ansehen
Petmed Express Inc Aktie (PETS) Neueste Nachrichten
PetIQ refocuses on pet health services, shares on NASDAQ under scrutiny - Ad-hoc-news.de
What makes PetMed Express, Inc. (PETS) one of the Best Pet Care Stocks to Buy for Consistent Recurring Revenue? - Yahoo Finance
Petmed Express Inc (PETS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Petmed Express Inc (PETS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Petmed Express Inc (PETS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Petmed Express Inc (PETS) Institutional Confidence - TradingKey
Petmed Express Inc (PETS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Petmed Express Inc (PETS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PetMed Express StockAnalyst views and operations midweek - Ad-hoc-news.de
Petmed Express Inc (PETS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PETS News | PETMED EXPRESS INC (NASDAQ:PETS) - ChartMill
Q4 2026 Petmed Express Inc Earnings Call Transcript - GuruFocus
Petmed Express Inc (PETS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Petmed Express Inc (PETS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PETMED EXPRESS INC (PETS) Stock Chart - ChartMill
NINA CAPITAL HOLDINGS INC. Increases Stake in PetMed Express Inc (PETS) - GuruFocus
Nina Capital Holdings buys $43,725 of PetMed Express common stock By Investing.com - Investing.com Nigeria
Nina Capital Holdings buys $43,725 of PetMed Express common stock - Investing.com
Nina Capital buys 25,000 PetMed Express (PETS) shares in market - Stock Titan
PETS Q4 earnings call focuses on turnaround foundation - MSN
PETS Q4 Earnings Call Focuses on Turnaround Foundation - TradingView
PetMed Express (PETS) Q4 2026 Earnings Transcript - AOL.com
PetMed outlines $6.1M annualized savings while staying independent after $4-$4.25 proposals - MSN
PetMeds 2026 Annual Report: Strategic Growth, Customer Care, and Competitive Position in Pet Pharmacy E-Commerce - Minichart
PETS: Company Evaluates Acquisition Proposals but Remains Indepe - GuruFocus
PetMed Express Inc (PETS) Q4 2026 Earnings Call Highlights: Navi - GuruFocus
PetMed Express Inc (PETS) Stock Price, Trades & News - GuruFocus
Is PetMed Express Inc (PETS) Overselling Its Growth Potential? Q - GuruFocus
PetMed Express Q4 2026 Earnings Call Transcript - MarketBeat
PETS Reports Q4 Revenue Decline While Aiming for Future Growth - GuruFocus
PetMed Express (PETS) Reports Q4 Fiscal 2026 Earnings Amid Restr - GuruFocus
PetMed Express earnings missed by $0.06, revenue fell short of estimates - Investing.com Canada
PetMed FQ4 profit misses outlook, dismisses acquisition offers (PETS:NASDAQ) - Seeking Alpha
PetMed (PETS) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
PETMED EXPRESS INC FY 2026: Revenue $179.02M, EPS ($2.74) — 10-K Summary - TradingView
PetMed Express (NASDAQ: PETS) highlights going-concern review and control weaknesses - Stock Titan
PetMed Express Reports Q4 2026 Results: Full Earnings Call Transcript - Benzinga
PetMed Express Fiscal Q4 Loss Narrows, Revenue Falls - Moomoo
PetMed: Fiscal Q4 Earnings Snapshot - marketscreener.com
PetMed Express reports FY2026 sales $179.0M, net loss $57.3M; Q4 sales $42.8M - TradingView
PetMed Express misses Q4 earnings, revenue estimates; Shares edge lower - Investing.com
PetMed Express misses Q4 earnings, revenue estimates; Shares edge lower By Investing.com - Investing.com India
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results - The Manila Times
PetMed Express Q4 revenue falls on prescription sales decline - TradingView
PetMed Express (PETS) revenue falls 21% as goodwill charge drives $57M loss - Stock Titan
PETS: FY26 net loss widened on lower sales and one-time charges; B2B and cost initiatives underway - TradingView
BRIEF-Petmed Express Q4 Revenue USD 42.8 Million - TradingView
PetMeds rejects $4.00–$4.25 a share bids, remains independent - Stock Titan
PetMed Express Inc stock (US7167831061): Investors watch ahead of next earnings date estimate - AD HOC NEWS
Petmed Express Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Finanzdaten der Petmed Express Inc-Aktie (PETS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):